War in Ukraine: AESGP calls for solidarity and unity

Brussels, 15 March 2022 – As the current conflict in Ukraine unfolds, the European Self-Care Industry stands in solidarity with everyone affected by this terrible crisis. AESGP and its members are working hard to ensure continuity of supply and meet the self-care needs of all the people affected by the war.

As the world emerges from two years of harrowing pandemic, it is the people of Ukraine who are now at the forefront of our minds. The European Self-Care Industry stands in solidarity with the people impacted by the war in Ukraine and with all those who are affected by this terrible crisis. This display of unwarranted violence and destruction is cruel and causes immense human suffering and fear among the Ukrainian population, their expatriate relatives and fellow country neighbors.

Calling for solidarity and unity

Our mission and values as an organization are to bring countries and people together to advance health and well-being beyond borders, to inspire each other and progress together. It is for these reasons that we firmly believe in unity and dialogue.

As a healthcare-based industry dedicated to providing healthcare solutions to all people across the globe, we are working hard with our members, as part of the broader healthcare community, to ensure continuity of supply in Europe and deliver essential self-care products to the people affected by the war.

In solidarity with war-affected communities, our members are offering humanitarian support in the territories afflicted. This includes in-kind donations of medical supplies and wellness products (hygiene, food supplements, etc.) and financial support to international and local NGOs.

Monitoring impacts on our supply chain

As the current events in Ukraine and Russia unfold, impacts on the supply chains of our products in Ukraine or Russia, or other potential shortages related to this situation, become possible.

AESGP and its members are closely monitoring the situation to report any signs of supply chain disruptions, or any products at risk, to the competent authorities concerned and, in case of medicines, to the European Medicines Agency (EMA).

Share this article on :

Hi there!

Stay in the loop for AESGP news and events by signing up for our newsletter.